Azelis set to float on Euronext Brussels

By Jane Byrne contact

- Last updated on GMT

© GettyImages/PictureLake
© GettyImages/PictureLake

Related tags: IPO, Animal nutrition

Belgium headquartered, Azelis, a distributor of specialty chemicals and animal nutrition and food ingredients, today announced its initial public offering (IPO) and its intention to list its shares on the regulated market of Euronext Brussels.

According to reports on financial media outlets, Azelis is targeting a valuation of more than €5bn (US$6bn). 

The Antwerp-based company, which is owned by Swedish buyout firm EQT, said the IPO is expected to consist of newly created shares from a capital increase as well as a secondary component from existing shareholders.

It is seeking to raise around €880 million via the process.

The company outlined how the proceeds would go some way to repaying outstanding debt, while providing it with increased financial flexibility; it also expects the IPO to support the company’s growth strategy and future acquisitions by providing funding and giving it access to capital markets.

Dr Hans Joachim Müller, CEO, Azelis, commented: “We have made great progress with the support of EQT in delivering our growth strategy to date, establishing ourselves as a market leading innovation service provider for the specialty chemicals and food ingredients industry.

“However, there remains great opportunity ahead. As a public company, we believe we will be able to fully capitalize on growth opportunities, continuing to complement our strong organic growth with accretive acquisitions.

“We are focused on being the preeminent global innovation service provider for the specialty chemicals and food ingredients distribution market."

On the asset trail 

In its announcement about the pending IPO, Azelis flagged the “leading role”​ it has played in market consolidation among specialty chemicals and food ingredients distributors, having completed 21 acquisitions from January 2018 through June 2021.

In July it acquired French company, Quimdis, a French distributor of ingredients for nutraceuticals, flavor and fragrances, animal nutrition, personal care, pharma and food.

That deal, it said, would enhance its lateral value chain by diversifying and expanding its presence in France and EMEA, while providing it with synergistic opportunities in animal nutrition. 

Related topics: Markets, Europe, Functional additives

Related news

Related products

Yeast nucleotides improve pig liver health

Yeast nucleotides improve pig liver health

Angel Yeast Co., Ltd. | 07-Jul-2022 | Research Study

Liver is one of the important organs in pigs. It has the functions of nutritional metabolism, detoxification, digestion and immunity, and 85% of pig diseases...

Related suppliers

Follow us


View more